Best Practice & Research Clinical Rheumatology
Volume 23, Issue 4 , Pages 457-467 , August 2009

Assessment of disease activity and quality of life in systemic lupus erythematosus – New aspects

  • Chee-Seng Yee, MRCP, PhD (Post-doctoral Clinical Research Fellow)

      Affiliations

    • Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 121 4146778; Fax: +44 121 4146794.
    • ,
  • Kathleen McElhone, PhD (Rheumatology Research Associate)

      Affiliations

    • Department of Rheumatology, Royal Blackburn Hospital, Haslingden Road, Blackburn BB2 3HH, UK
    • ,
  • Lee-Suan Teh, MD, FRCP (Consultant Rheumatologist)

      Affiliations

    • Department of Rheumatology, Royal Blackburn Hospital, Haslingden Road, Blackburn BB2 3HH, UK
    • ,
  • Caroline Gordon, MD, FRCP (Professor of Rheumatology)

      Affiliations

    • Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK

References 

  1. Moss KE, Ioannou Y, Sultan SM, et al. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002 May;61(5):409–413
  2. Isenberg D, Ramsey-Goldman R. Assessing patients with lupus: towards a drug responder index. Rheumatology (Oxford). 1999 Nov;38(11):1045–1049
  3. Mukhtyar C, Boumpas D, Gordon C, et al. Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus. Ann Rheum Dis. 2007 May;66(5):569–570
  4. Liang MH, Socher SA, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum. 1988 Jul;31(7):817–825
  5. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 Jun;35(6):630–640
  6. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002 Feb;29(2):288–291
  7. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 Dec 15;353(24):2550–2558
  8. Yee CS, Isenberg DA, Prabu A, et al. BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000. Ann Rheum Dis. 2008 Jun;67(6):873–876
  9. Symmons DP, Coppock JS, Bacon PA, et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). QJM. 1988 Nov;69(259):927–937
  10. Hay EM, Bacon PA, Gordon C, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJM. 1993 Jul;86(7):447–458
  11. Isenberg DA, Rahman A, Allen E, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005 Jul;44(7):902–906
  12. Yee CS, Farewell V, Isenberg DA, et al. Revised British Isles Lupus Assessment Group 2004 index: A reliable tool for assessment of systemic lupus erythematosus activity. Arthritis Rheum. 2006 Sep 28;54(10):3300–3305
  13. Yee CS, Farewell V, Isenberg DA, et al. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 2007 Dec;56(12):4113–4119
  14. Sivaraj RR, Durrani OM, Denniston AK, et al. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford). 2007 Dec;46(12):1757–1762
  15. Lee CK, Ahn MS, Lee EY, et al. Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis. 2002 Jun;61(6):547–550
  16. Hallegua DS, Wallace DJ. Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheumatol. 2000 Sep;12(5):379–385
  17. Ferrans CE. Definitions and conceptual models of quality of life. In:  Lipscomb J,  Gotay CC,  Snyder C editor. Outcome assessment in cancer. Measures, methods, and applications. Cambridge University Press; 2005;p. 14–30
  18. McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus. 2006;15(10):633–643
  19. Maeshima E, Maeshima S, Mizobata R, et al. Life-style activities in systemic lupus erythematosus. Clin Exp Rheumatol. 2007 Mar;25(2):189–194
  20. Bultink IE, Turkstra F, Dijkmans BA, Voskuyl AE. High prevalence of unemployment in patients with systemic lupus erythematosus: association with organ damage and health-related quality of life. J Rheumatol. 2008;35:1053–1057
  21. Strand V, Aranow C, Cardiel MH, et al. Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo. Lupus. 2003;12(9):677–686
  22. US Department of Health and Human Services. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. 2006 Feb.
  23. Curry SL, Levine SB, Corty E, et al. The impact of systemic lupus erythematosus on women's sexual functioning. J Rheumatol. 1994 Dec;21(12):2254–2260
  24. Fayers PM, Machin D. Introduction. In:  Fayers PM,  Machin D editor. Quality of Life assessment, analysis and interpretation. John Wiley & Sons Ltd; 2000;p. 3–27
  25. Thumboo J, Strand V. Health-related quality of life in patients with systemic lupus erythematosus: an update. Ann Acad Med Singapore. 2007 Feb;36(2):115–122
  26. Jones PW. Quality of life measurement: the value of standardisation. Eur Respir Rev. 1997;7(42):46–49
  27. Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol. 2001 Mar;28(3):525–532
  28. Costa DD, Bernatsky S, Dritsa M, et al. Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum. 2005 Apr 15;53(2):272–278
  29. Huang HC, Chou CT, Lin KC, Chao YF. The relationships between disability level, health-promoting lifestyle, and quality of life in outpatients with systemic lupus erythematosus. J Nurs Res. 2007 Mar;15(1):21–32
  30. Hale ED, Treharne GJ, Norton Y, et al. ‘Concealing the evidence’: the importance of appearance concerns for patients with systemic lupus erythematosus. Lupus. 2006;15(8):532–540
  31. Stamm TA, Bauernfeind B, Coenen M, et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum. 2007 Oct 15;57(7):1287–1295
  32. Curtis JR, Deyo RA, Hudson LD. Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax. 1994 Feb;49(2):162–170
  33. Kuriya B, Gladman DD, Ibanez D, Urowitz MB. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum. 2008 Feb 15;59(2):181–185
  34. Doward LC, McKenna SP, Whalley D, et al. The development of the L-QoL: A quality of life instrument specific to Systemic Lupus Erythematosus. Ann Rheum Dis. 2008 Apr 2;
  35. Grootscholten C, Ligtenberg G, Derksen RH, et al. Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Qual Life Res. 2003 Sep;12(6):635–644
  36. Leong KP, Kong KO, Thong BY, et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQoL). Rheumatology (Oxford). 2005 Oct;44(10):1267–1276
  37. Wiginton KL. Illness representations: mapping the experience of lupus. Health Educ Behav. 1999 Aug;26(4):443–453
  38. Kong KO, Ho HJ, Howe HS, et al. Cross-cultural adaptation of the Systemic Lupus Erythematosus Quality of Life Questionnaire into Chinese. Arthritis Rheum. 2007 Aug 15;57(6):980–985
  39. McElhone K, Abbott J, Shelmerdine J, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum. 2007 Aug 15;57(6):972–979
  40. Jolly M, Pickard AS, Wilke C, et al. Lupus specific health outcome measure for US Patients: The LupusQoL- US Version©. Ann Rheum Dis. 2009;
  41. Krupp LB, LaRocca NG, Muir J, Steinberg AD. A study of fatigue in systemic lupus erythematosus. J Rheumatol. 1990 Nov;17(11):1450–1452
  42. Taylor J, Skan J, Erb N, et al. Lupus patients with fatigue-is there a link with fibromyalgia syndrome?. Rheumatology (Oxford). 2000 Jun;39(6):620–623
  43. Omdal R, Waterloo K, Koldingsnes W, et al. Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects. J Rheumatol. 2003 Feb;30(2):283–287
  44. Wysenbeek AJ, Leibovici L, Weinberger A, Guedj D. Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression. Br J Rheumatol. 1993 Jul;32(7):633–635
  45. Bruce IN, Mak VC, Hallett DC, et al. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis. 1999 Jun;58(6):379–381
  46. Wang B, Gladman DD, Urowitz MB. Fatigue in lupus is not correlated with disease activity. J Rheumatol. 1998 May;25(5):892–895
  47. Lwin CT, Bishay M, Platts RG, et al. The assessment of fatigue in primary Sjogren's syndrome. Scand J Rheumatol. 2003;32(1):33–37
  48. Zonana-Nacach A, Roseman JM, McGwin G, et al. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture. Lupus. 2000;9(2):101–109
  49. Tayer WG, Nicassio PM, Weisman MH, et al. Disease status predicts fatigue in systemic lupus erythematosus. J Rheumatol. 2001 Sep;28(9):1999–2007
  50. Seawell AH, Danoff-Burg S. Psychosocial research on systemic lupus erythematosus: a literature review. Lupus. 2004;13(12):891–899
  51. Stoll T, Gordon C, Seifert B, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol. 1997 Aug;24(8):1608–1614
  52. Stoll T, Stucki G, Malik J, et al. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus. Ann Rheum Dis. 1996 Oct;55(10):756–760
  53. Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue . Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Rheum. 2007 Dec 15;57(8):1348–1357
  54. Gordon C, Clarke AE. Quality of life and economic evaluation in SLE clinical trials. Lupus. 1999;8(8):645–654
  55. Karlson EW, Liang MH, Eaton H, et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum. 2004 Jun;50(6):1832–1841
  56. Haupt M, Millen S, Janner M, et al. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis. 2005 Nov;64(11):1618–1623
  57. Grootscholten C, Snoek FJ, Bijl M, et al. Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial. J Rheumatol. 2007 Aug;34(8):1699–1707
  58. Dussan K, Magder L, Brodsky R, et al. High dose cyclophosphamide performs better than monthly dose cyclophosphamide in quality of life measures. Lupus. 2008;17(12):1079–1085
  59. Bertsias GK, Ioannidis JP, Boletis J, et al. Evidence for selection of end-points for clinical trials in systemic lupus erytematosus (SLE): a systematic literature review. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2008 Apr 23;
  60. Gordon C, Bertsias GK, Ioannidis JP, et al. EULAR recommendations for points to consider in conducting clinical trials in systemic lupus erythematosus (SLE). Ann Rheum Dis. 2008 Apr 3;
  61. Liang M, Fortin P, Schneider M, et al. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum. 2004 Nov;50(11):3418–3426
  62. Wollaston SJ, Farewell VT, Isenberg DA, et al. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group. J Rheumatol. 2004 Dec;31(12):2390–2394
  63. Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 1999 Jul;42(7):1354–1360
  64. Gladman DD, Goldsmith CH, Urowitz MB, et al. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol. 1994 Aug;21(8):1468–1471
  65. Gladman DD, Goldsmith CH, Urowitz MB, et al. Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol. 1992 Apr;19(4):608–611

PII: S1521-6942(09)00008-4

doi: 10.1016/j.berh.2009.01.007

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 4 , Pages 457-467 , August 2009

Article Tools